Corbevax gets DCGI nod as heterologous COVID-19 booster dose | Immune modulator drugs improves survival for people hospitalised with COVID-19 | Researchers devise age-based eligibility method to measure vaccine effectiveness in data-deficient scenarios | Japan study shows women more likely to get skin rash from Moderna shot